Literature DB >> 16179764

VEMPs and dynamic posturography after intratympanic gentamycin in Menière's disease.

Pasqualina M Picciotti1, Antonella Fiorita, Walter Di Nardo, Nicola Quaranta, Gaetano Paludetti, Maurizio Maurizi.   

Abstract

In this study, we investigated whether vestibular evoked myogenic potentials (VEMPs) and dynamic posturography (DP) are useful in the evaluation of the vestibular function in patients affected by active monoaural Menière's disease (MD) treated with intratympanic gentamycin. Twelve subjects affected by monoaural MD were treated with weekly intratympanic injections of 0.5 ml of gentamycin at a concentration of 20 mg/ml. VEMPs were used to test saccular function, while postural control was analyzed by DP. The results obtained with these two techniques were compared with those obtained by using bithermal caloric test. The mean follow-up was 15.3 months (6--28 months). Therapy resulted in complete absence of the caloric response in six subjects (50) and in caloric test-induced asymmetry in the remaining individuals, ranging from 83 to 27. At follow-up, eleven patients (91.6%) were free of vertigo, while one patient had two vertigo spells 9 months after treatment. Before treatment, VEMPs were present in the affected ear of eleven patients. After treatment VEMPs were absent in all the patients. At the end of follow-up, reappearance of VEMPs was observed in two patients, with no changes in latency values and amplitude ratio. DP demonstrated a reduction of the Composite Score (CS) one week after therapy, with a prevalent reduction of the vestibular component. After 6 months, there was an improvement of the CS and, in particular, of the vestibular component. The present study demonstrates that bithermal caloric test and VEMPs allow for the functional evaluation of both the horizontal semicircular canal and the sacculus, suggesting that these techniques might be used together to monitor the efficacy of intratympanic gentamycin therapy. In addition, our data indicate that DP might provide important information on compensation phenomena and show that intratympanic gentamycin can improve postural control in MD patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16179764

Source DB:  PubMed          Journal:  J Vestib Res        ISSN: 0957-4271            Impact factor:   2.435


  9 in total

1.  Air- and bone-conducted vestibular evoked myogenic potentials (VEMPs) in otosclerosis: recordings before and after stapes surgery.

Authors:  M Trivelli; L D'Ascanio; M Pappacena; F Greco; F Salvinelli
Journal:  Acta Otorhinolaryngol Ital       Date:  2010-02       Impact factor: 2.124

2.  Vestibular results after intratympanic gentamicin therapy in disabling Menière's disease.

Authors:  Philippe Junet; Alexandre Karkas; Georges Dumas; Jean Louis Quesada; Sébastien Schmerber
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-01-16       Impact factor: 2.503

3.  Intratympanic gentamicin treatment 'as needed' for Meniere's disease. Long-term analysis using the Kaplan-Meier method.

Authors:  Silvia Quaglieri; Omar Gatti; Elisabetta Rebecchi; Marco Manfrin; Carmine Tinelli; Eugenio Mira; Marco Benazzo
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-06-19       Impact factor: 2.503

4.  Vestibular evoked myogenic potentials in children affected by myelomeningocele.

Authors:  Pasqualina M Picciotti; Antonella Fiorita; Lea Calò; Mariapina Battista; Valentina Paolucci; Emanuele Ausili; Luca Massimi; Claudia Rendeli
Journal:  Childs Nerv Syst       Date:  2012-05-05       Impact factor: 1.475

5.  Author's reply to the Letter to the Editor "Therapeutic strategies in the treatment of Menière's disease: the Italian experience".

Authors:  N Quaranta; P Picciotti
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-03-26       Impact factor: 2.503

6.  Ocular vestibular evoked myogenic potential using different test stimuli.

Authors:  Dessai Teja Deepak; Jayashree S Bhat; Kaushlendra Kumar
Journal:  ISRN Otolaryngol       Date:  2013-08-06

7.  One-shot, low-dosage intratympanic gentamicin for Ménière's disease: Clinical, posturographic and vestibular test findings.

Authors:  Ahmad Daneshi; Hesam Jahandideh; Seyed Behzad Pousti; Shabahang Mohammadi
Journal:  Iran J Neurol       Date:  2014

8.  Intratympanic Gentamicin for Intractable Ménière's Disease - A Review and Analysis of Audiovestibular Impact.

Authors:  Sertaç Yetişer
Journal:  Int Arch Otorhinolaryngol       Date:  2017-07-17

9.  Refractory episodic vertigo: role of intratympanic gentamicin and vestibular evoked myogenic potentials.

Authors:  Erika Celis-Aguilar; Ramon Hinojosa-González; Olivia Vales-Hidalgo; Heloisa Coutinho-Toledo
Journal:  Braz J Otorhinolaryngol       Date:  2016-03-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.